Most older Americans object to cancer screening cutoffs based on life expectancy: Poll
Sep 29, 2023
Even among “medical minimizers,” who avoid medical intervention unless necessary, 57% disagreed with using life expectancy to determine who gets screenings.
U.S. declares monkeypox a public health emergency
Aug 04, 2022
The declaration will increase public awareness and education around monkeypox as well as increase testing and tracking of cases.
Myocarditis, myopericarditis risk up after SARS-CoV-2 vaccination
Dec 17, 2021
SARS-CoV-2 mRNA vaccination is associated with a significantly increased risk for myocarditis or myopericarditis for those receiving the mRNA-1273 (Moderna) vaccine and among females receiving the BNT162b2...
CDC reports first American with new bird flu
Apr 29, 2022
The CDC notes that the risk to the general public is still low, however.
More older Americans use online patient portals to access care
May 24, 2023
Better outreach and training are needed to help patients understand and use portal systems, researchers say.
As monkeypox cases spike, U.S. orders more vaccine, boosts testing
Jul 15, 2022
As of July 14, 1,470 cases of monkeypox have been identified in 44 jurisdictions in the United States.
Second death in trial of experimental Alzheimer’s drug raising concerns
Nov 29, 2022
Doctors suspect that by stripping away amyloid deposits, lecanemab weakens blood vessels and leaves them vulnerable to bleeds.
Eight in 10 seniors see wisdom of dementia screening
Jul 20, 2023
Only about one in five has had such screening in the past year, however.
Staffing shortages at nursing homes continue: report
Mar 01, 2024
Although the pandemic has ended, staffing shortages and employee burnout still plague US nursing homes, a new government report finds.
FDA approves second drug for Alzheimer’s disease, despite safety concerns
Jan 06, 2023
The approval of lecanemab-irmb (Leqembi) comes after controversial approval in 2021 of aducanumab (Aduhelm), which met with criticism over concerns about that drug’s effectiveness, safety and pricing.